Loading: 100%
NATURAL HEALTH TRENDS CORP logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees (as per )no data available
Sector Consumer Packaged Goods, Consumer DefensiveConsumer Packaged Goods, Consumer Defensiveno data available
Ticker NHTCno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Jan. 00Jan. 10Jan. 20Jan. 30Jan. 40Jan. 500,00,51,01,52,0
datesClosing price
01.01.20151.00
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per , in USD
n/a
Market Capitalisation
in million USD
0n/a
Enterprise Value
in million USD
0n/a
Common Shares Outstanding
as per Jul 28, 2017
11,341,890n/a
Preferred Shares Outstanding
as per Jul 28, 2017
123,693n/a
Average Basic Shares Outstanding
TTM
11,223,500n/a
Average Diluted Shares Outstanding
TTM
11,245,000n/a
Index Membership
n/a
Business Summary
Natural Health Trends Corp is engaged in the direct selling industry, selling lifestyle enhancement products, cosmetics, personal care and dietary supplements, and also what is called network marketing or multi-level marketing.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 0n/a
Receivables 0n/a
Total Current Assets 0n/a
PP&E 0n/a
Total Assets 0n/a
Accounts Payable 0n/a
Current Debt 0n/a
Total Current Liabilities 0n/a
Long-Term Debt 0n/a
Total Liabilities 0n/a
Total Equity 0n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value n/a
Other Ratios
Current Ratio 0.0%n/a
Liabilities to Equity Ratio 0.0%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (20 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net sales
24
31
38
53
125
265
288
Cost of sales
7
8
10
13
27
54
55
Gross Profit
17
23
28
40
98
211
233
Commissions expense
9
12
16
24
57
127
125
Selling, general and administrative expenses
10
9
9
12
20
36
43
Depreciation and amortization
1
0
0
0
0
0
0
Total operating expenses
20
21
25
36
77
163
169
Income from operations
-3
2
3
4
21
48
64
Gain on foreign exchange
1
0
0
0
0
0
0
Interest income
0
0
0
0
0
0
0
Interest expense
0
0
0
0
0
0
0
Other
0
0
0
0
0
0
0
Other expense, net
1
0
0
0
0
0
0
Income before income taxes
-2
2
3
4
21
48
64
Income tax provision
0
0
0
0
0
1
9
Net income
-2
2
0
0
0
0
0
Less: Net income attributable to noncontrolling interest
0
0
0
0
0
0
0
Net income
-2
2
3
4
20
47
55
Preferred stock dividends
0
0
0
0
0
0
0
Net income available to common stockholders
-2
2
3
4
20
47
55
Remarks
restated on Mar 27, 2012 n/a
calculated values,
restated on Mar 12, 2013 n/a
calculated values,
restated on Mar 7, 2014 n/a
calculated values,
restated on Mar 6, 2015 n/a
calculated values,
restated on Mar 10, 2017 n/a
calculated values,
restated on Mar 10, 2017 n/a
calculated values,
restated on Mar 10, 2017 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (35 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash and cash equivalents
1
2
4
15
45
105
126
Restricted cash
0
0
0
0
0
0
0
Accounts receivable
0
0
0
0
0
0
0
Inventories, net
1
1
1
2
4
10
11
Other current assets
1
1
1
1
1
2
4
Total current assets
3
4
6
17
50
118
141
Property and equipment, net
0
0
0
0
0
1
1
Goodwill
2
2
2
2
2
2
2
Intangible assets, net
0
0
0
0
0
0
0
Restricted cash
0
0
0
0
0
3
3
Other assets
0
0
0
0
0
1
1
Total assets
5
6
8
20
53
124
148
Liabilities and owners' equity
Accounts payable
3 3115000
2 2208000
1 1385000
3 3058000
2 2232000
3 2862000
2 2145000
Income taxes payable
0 330000
0 11000
0 10000
0 25000
0 268000
0 379000
1 663000
Accrued commissions
1 723000
1 1177000
1 1308000
4 3962000
9 8853000
20 19634000
14 13611000
Other accrued expenses
2 1792000
1 1471000
2 1688000
3 3146000
7 6743000
17 16703000
15 14989000
Deferred revenue
1 1029000
1 967000
1 836000
3 2569000
3 2687000
4 4011000
5 4948000
Amounts held in eWallets
0 0
0 0
0 0
0 0
2 2064000
16 16414000
19 19165000
Other current liabilities
1 1017000
1 950000
1 991000
1 882000
2 1513000
2 1510000
2 1633000
Total current liabilities
8 8184000
7 6932000
6 6310000
14 13750000
24 24425000
62 61513000
57 57154000
Deferred Tax Liabilities, Net, Noncurrent
0 178000
0 148000
0 92000
0 108000
0 65000
0 60000
0 268000
Long-term incentive
0 0
0 0
0 0
0 0
2 1665000
6 5770000
8 8190000
Total liabilities
0 0
0 0
0 0
14 13750000
26 26090000
67 67343000
66 65612000
Commitments and contingencies
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Preferred stock
0 124000
0 124000
0 124000
0 111000
0 0
0 0
0 0
Common stock
0 11000
0 11000
0 11000
0 11000
0 13000
0 13000
0 13000
Additional paid-in capital
80 80414000
80 80493000
81 80584000
81 80690000
86 85750000
86 85963000
87 86574000
Retained earnings (accumulated deficit)
-84 -83643000
-81 -81338000
-79 -78708000
-75 -74619000
-55 -54799000
-10 -9647000
39 38548000
Accumulated other comprehensive (loss) income
0 366000
0 -99000
0 -102000
0 -81000
0 62000
0 -101000
-1 -807000
Treasury stock, at cost
0 0
0 0
0 0
0 -35000
-5 -4576000
-19 -19419000
-42 -41889000
Total stockholders’ equity
-3 -2821000
-1 -809000
2 1909000
0 0
0 0
0 0
0 0
Total stockholders’ equity
-3 -2728000
0 0
0 0
6 6077000
26 26450000
57 56809000
82 82439000
Noncontrolling Interest
0 -93000
0 0
0 0
0 0
0 0
0 0
0 0
Total liabilities and stockholders’ equity
5 5363000
6 6123000
8 8219000
20 19827000
53 52540000
124 124152000
148 148051000
Remarks restated on Mar 27, 2012 n/a restated on Mar 12, 2013 n/a restated on Mar 7, 2014 n/a restated on Mar 6, 2015 n/a restated on Mar 4, 2016 n/a restated on Mar 10, 2017 n/a restated on Aug 2, 2017 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (33 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net income
-2
2
3
4
20
47
55
Depreciation and amortization
0
0
0
0
0
0
0
Amortization of intangibles
1
0
0
0
0
0
0
Stock-based compensation
0
0
0
0
0
0
0
Loss on disposal of property and equipment
0
0
0
0
0
0
0
Gain On Liquidation Of Subsidiary
0
0
0
0
0
0
0
Cumulative translation adjustment realized in net income
0
0
0
0
0
0
0
Accounts receivable
0
0
0
0
0
0
0
Deferred income tax expense (benefit)
0
0
0
0
0
0
0
Inventories, net
0
0
0
-1
-2
-7
-1
Other current assets
1
0
0
0
-1
-1
-2
Other assets
1
0
0
0
0
0
0
Accounts payable
1
-1
-1
2
-1
1
-1
Income taxes payable
0
0
0
0
0
0
0
Accrued commissions
0
0
0
3
5
11
-6
Other accrued expenses
0
0
0
1
4
11
0
Deferred revenue
-2
0
0
2
0
1
1
Amounts held in eWallets
0
0
0
0
2
14
3
Other current liabilities
0
0
0
0
1
0
0
Long-term incentive
0
0
0
0
2
4
2
Net cash provided by operating activities
0
1
2
11
31
81
53
Purchases of property and equipment
0
0
0
0
0
-1
-1
Increase in restricted cash
0
0
0
0
0
-3
0
Net cash reduction from liquidation of MyLexxus Europe
0
0
0
0
0
0
0
Advance from related party
0
0
0
0
0
0
0
Repayment to related party
0
0
0
0
0
0
0
Net cash used in investing activities
0
0
0
0
0
-4
-1
Proceeds from exercise of warrants
0
0
0
0
5
0
0
Repurchase of common stock
0
0
0
0
-5
-16
-24
Dividends paid
0
0
0
0
0
-2
-7
Net cash used in financing activities
0
0
0
0
0
-17
-31
Effect of exchange rates on cash and cash equivalents
-1
0
0
0
0
0
-1
Net increase in cash and cash equivalents
-1
1
3
10
30
60
21
Remarks
restated on Mar 27, 2012 n/a
calculated values,
restated on Mar 12, 2013 n/a
calculated values,
restated on Mar 7, 2014 n/a
calculated values,
restated on Mar 6, 2015 n/a
calculated values,
restated on Mar 10, 2017 n/a
calculated values,
restated on Mar 10, 2017 n/a
calculated values,
restated on Mar 10, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo